Skip to main content
. 2022 Aug 8;182(9):953–962. doi: 10.1001/jamainternmed.2022.3050

Table 1. Baseline Characteristics.

Characteristic or risk factor No. (%)
All participants (n = 90) CON+ER group (n = 45) eTRE+ER group (n = 45)
Demographic characteristics
Age, mean (SD), y 43 (11) 43 (11) 43 (10)
Sex
Female 72 (80) 37 (82) 35 (78)
Male 18 (20) 8 (18) 10 (22)
Race
Asian 2 (2) 1 (2) 1 (2)
Black 30 (33) 15 (33) 15 (33)
White 56 (62) 28 (62) 28 (62)
>1 Race 2 (2) 1 (2) 1 (2)
Ethnicity
Hispanic 2 (2) 1 (2) 1 (2)
Not Hispanic 85 (94) 41 (91) 44 (98)
Unknown or not reported 3 (3) 3 (7) 0
Body composition
Height, mean (SD), cm 165.5 (8.7) 163.8 (7.2) 167.3 (9.7)
Weight, mean (SD), kg 108.8 (20.6) 105.3 (20.7) 112.3 (20.1)
Fat mass 52.5 (14.4) 50.6 (14.8) 54.4 (13.9)
Fat-free mass 56.3 (11.1) 54.8 (10.7) 57.8 (11.4)
BMI, mean (SD) 39.6 (6.7) 39.2 (6.8) 40.1 (6.6)
Cardiometabolic risk factors
Blood pressure, mean (SD), mm Hg
Systolic 124 (13) 122 (11) 126 (14)
Diastolic 81 (9) 80 (8) 82 (9)
Heart rate, mean (SD), beats/mina 74 (10) 74 (12) 74 (8)
Glucose, mean (SD), mg/dL 105 (16) 103 (14) 107 (17)
Insulin, mean (SD), µIU/mLa 19.6 (14.1) 17.2 (9.5) 22.0 (17.2)
HOMA-IR, mean (SD) 5.24 (4.40) 4.44 (2.88) 6.02 (5.41)
HOMA-β, mean (SD) 181 (118) 170 (97) 192 (135)
HbA1c, mean (SD), % 5.5 (0.4) 5.5 (0.4) 5.5 (0.4)
Cholesterol, mean (SD), mg/dL
Total 203 (38) 202 (36) 204 (41)
LDL 118 (28) 117 (26) 119 (29)
HDL 62 (15) 61 (16) 62 (14)
Triglycerides, mean (SD), mg/dL 117 (64) 118 (62) 117 (67)
Eating habits, mean (SD)
Eating duration, h/d 12.6 (1.5) 12.8 (1.6) 12.4 (1.4)
Eating start time, h:m 7:29 (1:05) 7:27 (1:10) 7:31 (1:00)
Eating end time, h:m 20:06 (1:21) 20:14 (1:35) 19:57 (1:03)
Baecke Global Physical Activity Index 8.3 (1.0) 8.4 (1.0) 8.1 (0.9)

Abbreviations: BMI, body mass index, calculated as weight in kilograms divided by height in meters squared; CON+ER, control eating schedule plus energy restriction; eTRE+ER, early time-restricted eating plus energy restriction; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; HOMA-β, Homeostasis Model Assessment for β-cell Function, calculated as 360 × insulin/[glucose – 63], where the unit of measure for insulin is µIU/mL and the unit of measure for glucose is mg/dL; HOMA-IR, Homeostasis Model Assessment for Insulin Resistance, calculated as insulin × glucose/405, where the unit of measure for insulin is µIU/mL and the unit of measure for glucose is mg/dL; LDL, low-density lipoprotein.

SI conversion factors: To convert cholesterol mg/dL to mmol/L, multiply by 0.0259; glucose mg/dL to mmol/L, multiply by 0.0555; insulin µIU/mL to pmol/L, multiply by 6.945; triglycerides mg/dL to mmol/L, multiply by 0.0113.

a

One baseline value for heart rate in the eTRE+ER group and for insulin in the CON+ER group were excluded. See eMethods in Supplement 1.